Tuberoplasty Versus Balloon Spacer

January 5, 2026 updated by: University of Minnesota

Tuberoplasty Versus Balloon Spacer in Treatment of Rotator Cuff Tears

The purpose of this study is to examine bone-to-bone contact between the tuberosity as compared to a subacromial balloon spacer procedure. Using biplanar fluoroscopy to determine the three-dimensional (3D) motion of the shoulder compared pre-procedure to post-procedure, the investigators will be able to assess 1) the bone-to-bone contact of the tuberosity and acromion in the setting of a massive posterior superior rotator cuff tear 2) if the placement of a dermal allograft over the tuberosity does indeed decrease bone contact and 3) if the placement of a subacromial balloon spacer decreases bone-to-bone contact. Doing so will allow assessment of the relative contribution of the implant for arm elevation versus potential compensatory motion of increased scapulothoracic motion. The investigators will also be able to correlate this to patient-reported outcomes of pain and shoulder function.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55414
        • Recruiting
        • University of Minnesota
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus.
  • No involvement of the subscapularis.
  • Centered humeral head on X-ray examination.
  • Primary complaint of pain.
  • History of prior surgery, including failed rotator cuff repair.

Exclusion Criteria:

  • Involvement of the subscapularis.
  • Acromiohumeral distance less than 7 mm on upright anterior-posterior (AP) radiograph.
  • Rotator cuff deemed repairable at the time of surgery.
  • Patients younger than 65 years due to FDA clearance of the subacromial balloon spacer only for patients over 65

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: biologic tuberoplasty group
massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus, no involvement of the subscapularis, centered humeral head on X-Ray examination, and a primary complaint of pain, randomized to biologic tuberoplasty surgery.
a surgical procedure during which an a cellular dermal allograft is attached to the greater tuberosity to prevent bone-to-bone contact between the greater tuberosity and the acromion with the goal of decreasing pain
Experimental: subacromial balloon spacer group
massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus, no involvement of the subscapularis, centered humeral head on X-Ray examination, and a primary complaint of pain, randomized to subacromial balloon spacer.
a biodegradable balloon is inserted into the subacromial space of the shoulder to increase teh distance between the greater tuberosity and the acromion to reduce pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in bone-to-bone contact between tuberosity and acromion
Time Frame: presurgery, 6 months postop, 12 months postop
degree of change in bone-to-bone contact between tuberosity and acromion as assessed using biplanar fluoroscopy
presurgery, 6 months postop, 12 months postop
shoulder range of motion
Time Frame: presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively
quantitative measurement in degrees with a goniometer of shoulder motion in forward elevation, abduction, external rotation, and internal rotation
presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively
single assessment numerical evaluation (SANE) of the shoulder
Time Frame: presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively
a validated tool providing a numerical score from 0-100 that assess shoulder function as subjectively reported by the subject. A higher score indicates superior shoulder function.
presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively
American shoulder and elbow surgeons (ASES) score
Time Frame: presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively
a validated survey with possible scores from 0-100 that assesses shoulder function as reported by the subject. A higher score indicates superior shoulder function.
presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Allison Rao, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2024

Primary Completion (Estimated)

November 26, 2026

Study Completion (Estimated)

November 26, 2026

Study Registration Dates

First Submitted

December 3, 2024

First Submitted That Met QC Criteria

December 10, 2024

First Posted (Actual)

December 16, 2024

Study Record Updates

Last Update Posted (Actual)

January 7, 2026

Last Update Submitted That Met QC Criteria

January 5, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tears

Clinical Trials on biologic tuberoplasty

Subscribe